Vol 2014, No 6 (2014)

Table of Contents

Research & Development

Regeneron Looks to Avalanche’s Ocular BioFactory™ for Potential Eylea® Successor Abstract
Heather Cartwright
BMS Continues Immuno-Oncology Push via Deals with CytomX and Incyte Abstract
Heather Cartwright

Licensing

Janssen Strengthens Prostate Cancer Pipeline with Aduro BioTech Collaboration Abstract
Heather Cartwright

Mergers & Acquisitions

Merck & Co. Divests Nine Ophthalmology Brands to Japan’s Santen Pharmaceutical Abstract
Heather Cartwright
Lundbeck Adds to Neurology Portfolio with Chelsea Therapeutics Acquisition Abstract
Heather Cartwright
Abbott Targets Growth in Emerging Markets with CFR Pharmaceuticals Acquisition Abstract
Heather Cartwright
Hikma Builds Presence in US Injectables Market via Boehringer Ingelheim Asset Purchase Abstract
Heather Cartwright


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.